Article: RECKITT BENCKISER GROUP PLC - Acquisition Of Adams Respiratory Therapeutics.

 
10 December 2007 
 
 ACQUISITION OF ADAMS RESPIRATORY THERAPEUTICS 
 
 BY RECKITT BENCKISER 
 
Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") and Adams Respiratory 
Therapeutics (NASDAQ: ARxT) ("Adams") today announce that they have entered 
into a definitive agreement under which Reckitt Benckiser will tender for the 
acquisition of Adams for $60 per share in cash, representing a total 
consideration for Adams' fully diluted share capital of approximately $2.3bn (A[pounds sterling] 
1.1bn). This transaction will be financed by Reckitt Benckiser by cash on hand 
and existing credit facilities. 
 
Adams is a NASDAQ listed specialty ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!